BioGaia AB Shares Owned By Insiders vs. Net Income

BIOG-B Stock  SEK 108.80  0.80  0.74%   
Based on the measurements of profitability obtained from BioGaia AB's financial statements, BioGaia AB may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess BioGaia AB's ability to earn profits and add value for shareholders.
For BioGaia AB profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioGaia AB to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioGaia AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioGaia AB's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioGaia AB over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between BioGaia AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioGaia AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioGaia AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BioGaia AB Net Income vs. Shares Owned By Insiders Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BioGaia AB's current stock value. Our valuation model uses many indicators to compare BioGaia AB value to that of its competitors to determine the firm's financial worth.
BioGaia AB is number one stock in shares owned by insiders category among its peers. It also is number one stock in net income category among its peers making up about  104,061,838  of Net Income per Shares Owned By Insiders. Comparative valuation analysis is a catch-all model that can be used if you cannot value BioGaia AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioGaia AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

BioGaia Net Income vs. Shares Owned By Insiders

Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

BioGaia AB

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
3.59 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

BioGaia AB

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
373.58 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

BioGaia Net Income Comparison

BioGaia AB is currently under evaluation in net income category among its peers.

BioGaia AB Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in BioGaia AB, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioGaia AB will eventually generate negative long term returns. The profitability progress is the general direction of BioGaia AB's change in net profit over the period of time. It can combine multiple indicators of BioGaia AB, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 144 people.

BioGaia Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BioGaia AB. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioGaia AB position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioGaia AB's important profitability drivers and their relationship over time.

Use BioGaia AB in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioGaia AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioGaia AB will appreciate offsetting losses from the drop in the long position's value.

BioGaia AB Pair Trading

BioGaia AB Pair Trading Analysis

The ability to find closely correlated positions to BioGaia AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioGaia AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioGaia AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioGaia AB to buy it.
The correlation of BioGaia AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioGaia AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioGaia AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioGaia AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your BioGaia AB position

In addition to having BioGaia AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Emerging Markets Funds Thematic Idea Now

Emerging Markets Funds
Emerging Markets Funds Theme
Fund or Etfs that invest in markets of developing countries. The Emerging Markets Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in BioGaia Stock

To fully project BioGaia AB's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BioGaia AB at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BioGaia AB's income statement, its balance sheet, and the statement of cash flows.
Potential BioGaia AB investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although BioGaia AB investors may work on each financial statement separately, they are all related. The changes in BioGaia AB's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BioGaia AB's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.